ICON plc
Company Details
Linkedin ID:
icon-plc-2
Website:
Employees number:
36,427
Number of followers:
577,622
NAICS:
541714
Industry Type:
Homepage:
iconplc.com
IP Addresses:
0
Company ID:
ICO_2948584
Scan Status:
In-progress
ICON plc Company CyberSecurity Posture
iconplc.com
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.
ICON plc A.I CyberSecurity Scoring
ICON plc Risk Score (AI oriented)Between 750 and 799
ICON plc
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
ICON plc Global Score (TPRM)XXXX
ICON plc
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
ICON plc Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
ICON plc Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for ICON plc
Incidents vs Biotechnology Research Industry Average (This Year)
No incidents recorded for ICON plc in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for ICON plc in 2025.
Incident Types ICON plc vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for ICON plc in 2025.
Incident History — ICON plc (X = Date, Y = Severity)
ICON plc cyber incidents detection timeline including parent company and subsidiaries
ICON plc Company Subsidiaries
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.
Loading...
ICON plc Similar Companies
bioMérieux
A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in v
Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development an
The National Institutes of Health
NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness an
About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions s
Biocon
Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global heal
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to eac
About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research,
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy healt
.png)
ICON plc CyberSecurity News
September 04, 2025 07:00 AM
Major Leadership Change: ICON plc's 14-Year Veteran CEO Steps Down, COO Barry Balfe to Take Helm
ICON plc announces CEO Steve Cutler's retirement after 14 years with the company. COO Barry Balfe, appointed in January 2025, will succeed...
July 23, 2025 07:00 AM
ICON Clinical Research Earnings Soar 31% as Business Wins Hit $3B, Expands $1B Buyback Program
Clinical research leader posts $2.97B in business wins, raises full-year outlook. Board authorizes additional $500M for share repurchases.
July 07, 2025 07:00 AM
ICON Ranks #1 Among Global CROs in TIME Magazine Sustainable Growth List, Clinches AI Innovation Award
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number...
April 25, 2025 12:02 AM
ICLR - ICON PLC Latest Stock News & Market Updates
Discover ICON PLC, a global clinical research partner specializing in comprehensive clinical trials, pharmacovigilance, and drug development services.
February 11, 2025 08:00 AM
Researcher ICON Sued by Investor Over Revenue Miss Stock Dive
Clinical research conductor ICON Plc downplayed impacts from demand softness from the pharmaceutical and biotechnology industries,...
July 17, 2024 07:00 AM
UnitedHealth’s cyberattack response costs to surpass $2.3B this year
The healthcare giant's new estimate is roughly $1 billion higher than previous forecasts as the cyberattack on subsidiary Change Healthcare continues to hamper...
May 20, 2024 07:00 AM
ICON plc to hold Investor Day Meeting on May 30, 2024
DUBLIN --(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation,...
September 13, 2023 07:00 AM
ICON to partner with US government agency to test COVID vaccine candidates
Contract research firm ICON Plc said on Wednesday it is partnering with the U.S. government for a clinical trial to test the effectiveness...
April 05, 2021 07:00 AM
ICON Clinical Research faces ERISA complaint over 401(k) plan management
Former employees of ICON Clinical Research sued the company and fiduciaries alleging mismanagement of a company 401(k) plan.
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
ICON plc CyberSecurity History Information
Official Website of ICON plc
The official website of ICON plc is http://www.iconplc.com.
ICON plc’s AI-Generated Cybersecurity Score
According to Rankiteo, ICON plc’s AI-generated cybersecurity score is 795, reflecting their Fair security posture.
How many security badges does ICON plc’ have ?
According to Rankiteo, ICON plc currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does ICON plc have SOC 2 Type 1 certification ?
According to Rankiteo, ICON plc is not certified under SOC 2 Type 1.
Does ICON plc have SOC 2 Type 2 certification ?
According to Rankiteo, ICON plc does not hold a SOC 2 Type 2 certification.
Does ICON plc comply with GDPR ?
According to Rankiteo, ICON plc is not listed as GDPR compliant.
Does ICON plc have PCI DSS certification ?
According to Rankiteo, ICON plc does not currently maintain PCI DSS compliance.
Does ICON plc comply with HIPAA ?
According to Rankiteo, ICON plc is not compliant with HIPAA regulations.
Does ICON plc have ISO 27001 certification ?
According to Rankiteo,ICON plc is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of ICON plc
ICON plc operates primarily in the Biotechnology Research industry.
Number of Employees at ICON plc
ICON plc employs approximately 36,427 people worldwide.
Subsidiaries Owned by ICON plc
ICON plc presently has no subsidiaries across any sectors.
ICON plc’s LinkedIn Followers
ICON plc’s official LinkedIn profile has approximately 577,622 followers.
NAICS Classification of ICON plc
ICON plc is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).
ICON plc’s Presence on Crunchbase
Yes, ICON plc has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/icon-plc.
ICON plc’s Presence on LinkedIn
Yes, ICON plc maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/icon-plc-2.
Cybersecurity Incidents Involving ICON plc
As of December 11, 2025, Rankiteo reports that ICON plc has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
ICON plc has an estimated 4,470 peer or competitor companies worldwide.
ICON plc CyberSecurity History Information
How many cyber incidents has ICON plc faced ?
Total Incidents: According to Rankiteo, ICON plc has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at ICON plc ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.
Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.
Risk Information
cvss3
Base: 9.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
Description
Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.
Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:N
Description
Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.
Risk Information
cvss3
Base: 8.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:L
Description
The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.
Risk Information
cvss3
Base: 5.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:L/A:N
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=icon-plc-2' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
